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ABSTRACT 
Prokaryotic cell-free systems are currently heavily used for the production of 
protein that can be otherwise challenging to produce in cells. However, historically cell-
free systems were used to explore natural phenomena before the advent of genetic 
modification and transformation technology. Recently, synthetic biology has seen a 
resurgence of this historical use of cell-free systems as a prototyping tool of synthetic 
and natural genetic circuits. For these cell-free systems to be effective prototyping tools, 
an understanding of cell-free system mechanics must be established that is not purely 
protein-expression driven. Here we discuss the development of E. coli-based cell-free 
systems, with an emphasis on documenting published extract and energy preparation 
methods into a uniform format. We also discuss additional considerations when 
applying cell-free systems to synthetic biology.  
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INTRODUCTION 
Cell-free systems have historically been a fundamental tool for biological 
research. This was partially a necessity, as transformation technologies to introduce 
DNA into E. coli (Mandel & Higa, 1970) and modern recombinant DNA technology 
(Smith & Welcox, 1970) were not available until 1970. As a result, many scientific 
phenomena were limited to probing in crude lysates. The most-well known is 
Nirenberg’s use of a cell-free system to decipher the genetic code for the Nobel Prize in 
Medicine in 1968 (Nirenberg & Matthaei, 1961).  
When recombinant DNA technology became mainstream and working in cellular 
hosts the norm, cell-free systems were relegated to the production of hard-to-produce or 
high-value proteins such as antibodies (Ryabova, Desplancqh, & Spirin, 1997; Yin et al., 
2012) or cytotoxic agents (Martemyanov, Shirokov, Kurnasov, Gudkov, & Spirin, 2001; 
Salehi et al., 2016). Significant field focus has been on producing large amounts of 
proteins, either by engineering of the cell-free system itself (Kigawa, Yabuki, Yoshida, 
Tsutsui, & Ito, 1999) or through assisted methods of production (Spirin, Baranov, 
Ryabova, & Ovodov, 1988a). These methods all utilize the ability of cell-free systems to 
efficiently produce protein without interference from cellular growth and metabolism. In 
addition, many systems are driven by T7 RNA polymerase expression (Krieg & Melton, 
1987) to encourage as much protein production as possible. Completely “synthetic” cell-
free systems from purified components (Shimizu et al., 2001) have also been developed 
for hard-to-produce proteins. 
There has been a recent resurgence of using cell-free systems as a fundamental 
tool. An overview contrasting this approach to utilizing systems for expression is given 
in Figure 1. The goal is similar to original applications probing biological phenomena, 
but motivated by modern-day synthetic biology tools of DNA sequencing, synthesis, and 
assembly. The first implementation of this was in 2003, with genetic circuits in cell-free 
(Noireaux, Bar-Ziv, & Libchaber, 2003), followed by the high expression of native 
sigma70 promoters (Shin & Noireaux, 2010) and the implementation of a panel of native 
circuits (Shin & Noireaux, 2012). By uncoupling protein expression activity from cell-
growth requirements and opening the system to external manipulation and perturbation, 
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cell-free is increasingly being used as a “prototyping environment,” or an environment 
for testing hypotheses before final implementation (in a cell, or a cell-free environment) 
(Niederholtmeyer, Sun, Hori, & Yeung, 2015; Takahashi et al., 2014). The emphasis in 
this application is less on protein production and more on the data collected from the 
cell-free system itself.  
In this review, we focus on the development and application of cell-free systems 
in synthetic biology. This diverges from, but builds off of previous in-depth reviews that 
take a broad-focus of cell-free systems as an expression platform (Carlson, Gan, 
Hodgman, & Jewett, 2012; Hodgman & Jewett, 2012; James R Swartz, 2012; Jim 
Swartz, 2006) or focus on engineering in cell-free (Takahashi et al., 2015). In doing so, 
we will explore the extensive prior research in cell-free system production and energy 
regeneration, as well as methods of executing cell-free reactions.   
 
Figure 1. 
Overview of cell-
free expression 
process. 
Execution is split 
into expression 
(left) and 
prototyping (right). 
On the right, the 
prototyping of a 3-
node oscillator is 
represented. 
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E. coli  EXTRACT PREPARATION METHODS 
Since the earliest method for the cell-free synthesis of proteins was published by 
Nirenberg in 1961 (Nirenberg & Matthaei, 1961), numerous modified and improved 
protocols have been created. A detailed system published by Zubay in 1973 became 
what is considered to be the standard “S30” protocol upon which subsequent protocols 
were based (Spirin & Swartz, 2008; Zubay, 1973).  
Generally, these protocols share a common schematic with the following 
features: a specific strain of E. coli upon which the extract is based, a strategy for cell 
culture, an elected method for cellular lysis, a centrifugation step to clarify the lysate, a 
heat incubation (run-off), dialysis, and post-dialysis clarification. Although this remains a 
fairly faithful general representation of the extract preparation process, none of these 
parameters were left unexplored in later iterations of the cell-free system and 
accordingly, current protocols do deviate from this paradigm. We parse extract 
production into the component pieces specified and evaluate the developments 
targeting each step (Figure 2). 
 
Figure 2. Flow-chart schematic for extract preparation. Preparation is divided into: 
strain (red), growth conditions (orange), lysis (yellow), clarification (green), runoff 
determination (blue), and dialysis (purple). 
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Strain selection 
 
Selection of model organism is critical as different E. coli strains offer a variety of 
different advantages over one another. Strains are differentiated by their engineered 
traits, some of which are very conducive to the controlled expression of protein. Choice 
of organism presents the first unit of modularity in the construction of cell-free systems. 
Engineered properties critical to the development of new applications can be directly 
conferred from engineered strains to their extracts. E. coli extracts have been 
successfully produced from a number of different cell strains. We divide strain selection 
into 4 overlapping areas:  protein production-optimized strains, application-specific 
strains, generic strains, and pre-programmed pathway strains. Common genes over-
expressed and under-expressed are in Table 1, and common strains are in Table 2. 
 
Protein production optimized strains 
Increasing protein production yield has been one of the main focuses of cell-free 
optimization. Many of the strain modification findings in this area were pioneered by 
Swartz and colleagues from 2004 onwards. Earlier efforts on engineering cell-free 
systems focused on utilizing physical systems (D. M. Kim & Choi, 1996; Spirin, 
Baranov, Ryabova, Ovodov, & Alakhov, 1988b)) and engineering energy regeneration 
(Kigawa et al., 1999; Ryabova, Vinokurov, Shekhovtsova, Alakhov, & Spirin, 1995). 
However, in 2004 a seminal paper from Swartz et al. described deletions in genes 
encoding for amino acid degradation enzymes, thereby stabilizing amino acid supply 
and protein production (Michel-Reydellet, Calhoun, & Swartz, 2004). The paper 
identified four limiting amino acids: arginine, serine, tryptophan, and cysteine. Arginine 
was stabilized by removing speA, a gene encoding for a arginine decarboxylase, 
thereby inhibiting the conversion of arginine to putrescine. Serine was stabilized by 
removing serine deaminases sdaA and sdaB, inhibiting the conversion of serine to 
pyruvate. Tryptophan was stabilized by removing tnaA. There was an additional attempt 
to stabilize cysteine, but deletions in tnaA and yfhQ failed to achieve desired results. A 
follow-up paper identified a deletion in gshA, a glutamate-cysteine ligase, as the 
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cysteine degradation culprit (Calhoun & Swartz, 2006). The resulting strain was named 
KC6 (Calhoun & Swartz, 2005a; Michel-Reydellet et al., 2004). 
To stabilize templates off of which DNA can be translated, the lambda-phage 
cluster has also been inserted into strains made into cell-free lysates (Michel-Reydellet, 
Woodrow, & Swartz, 2005), creating the NMR5 strain. The insertion of lambda-phase 
cluster represented one of the first strain-engineering attempts at stabilizing linear DNA. 
Although the cluster was identified as exo and beta in (Michel-Reydellet et al., 2005), 
earlier efforts revealed gam, when added in purified form, to be the main RecBCD 
inhibitor and linear DNA stabilizer (Sitaraman et al., 2004). 
Separately, work from the Kim (HJ) lab in 2005 identified strains with the 
overexpression of molecular chaperones capable of reducing aggregation and improve 
solubility of eukaryotic proteins such as human erythropoietin (Kang et al., 2005). The 
work inserted plasmids to overexpress chaperone and heat-shock genes groEL/ES, 
dnaK/J and grpE, or dsbC. Interestingly, the Kim group also explored the creation of 
extracts from the Origami strain (Novagen) that encourages disulfide bond formation. 
The roles of proteins trxB, gor, and dsbC would for later formally explored in the context 
of disulfide bond formation in (Knapp, Goerke, & Swartz, 2007). 
With the success in engineering amino acid stability, high-throughput approaches 
for determining positive and negative factors to cell-free expression was explored. In a 
first attempt, Woodrow et al. expressed 55 genes from E. coli off of linear DNA 
templates in NMR5, and demonstrated gene expression (Kim A Woodrow, Isoken O 
Airen, & Swartz, 2006). This work was followed by an expression of 49 genes affecting 
transcription, folding, energy, and cell-division, coupled to a selective degradation of 
linear templates with DpnII (on methylation pattern) and a subsequent analysis of cell-
free yields (Woodrow & Swartz, 2007). In a final iteration, Airen (in unpublished but 
peer-reviewed thesis work) expressed 3,789 E. coli open reading frames, identifying 79 
positive effectors and 60 negative effectors (Airen, 2011). Using this information on 
negative effectors, 4 mutant strains were made that, when combined with (1) 
supplementation with positive effectors, (2) stabilization of pH, (3) substrate 
replenishment, and (4) mRNA stabilization were able to increase expression 3-4-fold. 
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While strains with 4 negative effectors removed, pnp, rnb, raiA, and mazG, did not result 
in significant increased expression, supplementation in ibpA, ibpB, if-1, if-2, if-3, and ef-
tu demonstrated increased yields (Airen, 2011; Woodrow & Swartz, 2007). Negative 
effectors rna, rnb, csdA, mazF, and endA have also been removed from newer MAGE-
recoded (H. H. Wang et al., 2009) strains, resulting in increased fluorescent protein 
yield. rna and rnb code for RNAses, csdA for a cold-shock protein that degrades mRNA, 
mazF for a RNA-degrading toxin, and endA for a dsDNA endonuclease (Hong et al., 
2015). 
 
Application specific strains 
Strain modifications have also been explored to enable the expression of 
proteins with disulfide bonds. Disulfide bonds are a common feature of mammalian 
proteins, but are difficult to implement in cell-free due to rapid reduction in vitro (Jim 
Swartz, 2006).  While iodoacetamide treatment can inactive thiols responsible for 
reducing disulfide bonds (Yin & Swartz, 2004), the treatment globally targets –SH 
groups and can result in non-specific inactivation of critical enzymes (such as DsbC and 
G-3PDH) (Knapp et al., 2007). A workaround was through the creation of a deletion 
mutant of trxB (thioredoxin reductase) and gor (glutathione reductase) and 
supplementation with DsbC. Critically, trxB is tagged with a hemagglutinin tag to allow 
for it to be present during cell growth but removed after cell-free processing, as a double 
trxB gor knockout causes ahpC to mutate to a potent disulfide reductase (Knapp et al., 
2007). It is noted that this genotype closely represents the Origami strain (Novagen) 
that contains knockouts of trxB and gor with suppressor mutations in ahpC, and was 
demonstrated successfully for cell-free production two years prior (Kang et al., 2005). 
The resulting strain (KGK10) or findings from engineering the strain form the basis for 
current production efforts of disulfide bond proteins. Commercially, Sutro Biopharma 
utilizes variants of the strain for producing cytokine rhGM-CSF at 200L scale (Zawada, 
Yin, Steiner, & Yang, 2011) and producing antibody fragment light and heavy chains 
(Yin et al., 2012). 
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Generic strains 
While strains can be specifically engineered for protein production or for specific 
applications, there is also a focus on using “generic” strains for cell-free prototyping. 
Reasons for using generic strains rather than specialized strains include: (1) Lack of 
need of high protein expression, and (2) the desire to maintain prototyping fidelity 
between in vitro and in vivo. Generic strains such as K19, first introduced in 1966 
(Gesteland, 1966), have been commonly used (Kigawa et al., 1999; D.-M. Kim, Kigawa, 
Choi, & Yokoyama, 1996), as well as MRE-600 (Spirin et al., 1988a), BL21-derivatives 
(CP strains (Kigawa, Yabuki, Matsuda, Matsuda, Nakajima, Tanaka, & Yokoyama, 
2004a), Rosetta strains ((de los Santos, Meyerowitz, Mayo, & Murray, 2015; Shin & 
Noireaux, 2012; Sitaraman et al., 2004; Sun et al., 2013; Sun, Yeung, Hayes, Noireaux, 
& Murray, 2014; Takahashi et al., 2014)), DE3 strains ((Karim & Jewett, 2016; Kwon & 
Jewett, 2015; Kwon et al., 2013), Origami strains ((Kang et al., 2005)), and K12 
MG1655 (Kwon & Jewett, 2015). These generic strains can be chosen for favorable 
properties of growth; for example, the Rosetta derivatives provide rare tRNAs, DE3-
derivatives provide T7 RNA Polymerase, BL21-derivatives are optimized for protein 
production, and Origami derivatives optimize for disulfide bond formation with txrB and 
gor deletions. However, selection does not need to be limited to widely recognized sub-
strains. For example, cells with lacI, araC, and tetR knockouts such as JS006 (Stricker 
et al., 2008) have been made into extracts to build oscillators that require exogenous 
lacI (Niederholtmeyer et al., 2015). In the reverse case, ExpressIQ (lacIQ) has been 
used to shut-down operons that are lacI sensitive (Sun, Kim, Singhal, & Murray, 2015). 
Commercially, cells optimized for 1,4-BDO production were used by Genomatica as the 
starting strain for lysis, to test hypotheses of expression efficiency (Fischer, 2016; 
Schilling, 2015). If using cell-free as a prototyping platform, where the data collected 
from cell-free systems is critical, the selection of strain is driven by the final in vivo 
implementation.  
 
Pre-programmed pathway strains 
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Recently, strains with complete pathways already present have also been made 
into cell-free systems for the purposes of driving production of a specific product. This is 
distinct from directed cell-free synthesis of products by the combination of separate cell-
free lysates, each with a single enzyme to drive catalysis, as exemplified by Zhang 
(YHP) and colleagues ((Rollin et al., 2015; Y. Wang, Huang, Sathitsuksanoh, Zhu, & 
Zhang, 2011).  
Greenlight Biosciences has pioneered a unique method to produce cell-free 
systems pre-programmed with metabolic pathways of the product of interest, where 
energy flux is solely directed towards producing the product (and not towards cellular 
growth). This is achieved by compartmentalizing the cell into a cytoplasm and a 
periplasm, where the cytoplasm contains the pathway of interest without a key enzyme 
and the periplasm contains the key enzyme and proteases against tagged proteins that 
are essential for cellular growth and function (but divert metabolic flux in vitro) (James R 
Swartz, 2012). Upon lysis, both compartments are brought together. The protease can 
then degrade the tagged growth-related proteins, while the key enzyme can run the 
pathway. This process can be achieved by engineering the strain to have protein 
degradation tags on growth-related proteins and periplasm-export tags on key enzymes. 
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Table 1. Genes commonly over-expressed or under-expressed in engineered cell-
free strains. Citations indicate where more information about the gene in the context of 
cell-free can be found. 
Gene Description Citation 
ackA+ acetate kinase, added to increase yield (Airen, 2011)  
csdA- cold shock degradosome protein, removed to prevent mRNA 
decay during preparation 
(Hong et al., 2015) 
dnaJ+ chaperone protein, added to assist folding with dnaK, grpE (Kang et al., 2005) 
dnaK+ chaperone protein, added to assist folding with dnaJ, grpE (Kang et al., 2005) 
dsbC+ disulfide isomerase, added for disulfide bond formation (J. Yang, Kanter, Voloshin, 
Levy, & Swartz, 2004; Yin & 
Swartz, 2004) 
ef-tu+ translation factor, added to increase yields (most abundant 
protein in cell, potentially rate-limiting) 
(Airen, 2011; Woodrow & 
Swartz, 2007) 
endA- endonuclease, removed for plasmid stability (Michel-Reydellet et al., 2004) 
gamS+ lambda gam, added to protect linear DNA (Michel-Reydellet et al., 2005; 
Sitaraman et al., 2004; Sun et 
al., 2014) 
gorB- glutathione reductase, removed to prevent disulfide bond 
persistence 
(Kang et al., 2005; Knapp et al., 
2007) 
groEJ+ chaperone protein, added to assist folding with groEL+ (Kang et al., 2005) 
groEL+ chaperone protein, added to assist folding with groEJ+ (Kang et al., 2005) 
grpE+ heat shock protein, added to assist folding with dnaJ, dnaK (Kang et al., 2005) 
gshA- glutamate-cysteine ligase, removed to stabilize cysteine  (Calhoun & Swartz, 2006) 
hchA+ chaperone protein, added to increase solubility and yield (Airen, 2011)  
ibpA+ small heat shock protein (chaperone), added to increase 
solubility and yield 
(Airen, 2011)  
ibpB+ small heat shock protein (chaperone), added to increase 
solubility and yield 
(Airen, 2011)  
If-1+ initiation factor 1, added to increase yield (Airen, 2011)  
If-2+ initiation factor 2, added to increase yield (Airen, 2011)  
If-3+ initiation factor 3, added to increase yield (Airen, 2011; Kim A Woodrow et 
al., 2006; Woodrow & Swartz, 
2007) US 20130316397 
lacI- lacI repressor, removed to prevent interference with lacI-
expressing circuits 
(Niederholtmeyer et al., 2015) 
mazF- mazF toxin, removed to prevent mRNA degradation at ‘ACA’ 
sites 
(Hong et al., 2015) 
met+ P1 selection marker, engineering scar (Michel-Reydellet et al., 2004) 
recD- recD, removed to protect linear DNA (ineffective) (Michel-Reydellet et al., 2005) 
rna- RNAse A, removed for RNA stability (Gesteland, 1966; D.-M. Kim et 
al., 1996) 
rnb- RNAse II, removed for RNA stability (Hong et al., 2015; Woodrow & 
Swartz, 2007) 
rpfA- release factor 1, removed to encourage nsAA incorporation (Hong et al., 2014) 
sdaA- serine deaminase, removed to stabilize serine (Michel-Reydellet et al., 2004) 
sdaB- serine deaminase, removed to stabilize serine (Michel-Reydellet et al., 2004) 
speA- arginine decarboxylase, removed to stabilize arginine (Michel-Reydellet et al., 2004) 
tnaA- tryptophanase, removed to stabilize tryptophan (Michel-Reydellet et al., 2004) 
tonA- outer membrane protein, engineering scar (Michel-Reydellet et al., 2004) 
trxB- thioredoxin reductase, removed post-growth with HA tag to (Kang et al., 2005; Knapp et al., 
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HA prevent disulfide bond persistence 2007) 
 
Table 2. Commonly used strains, with genotypes. Citations indicate originally 
developed locations and/or application 
Strain  Genotype Citation 
BL21-
Rosetta2 
F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 
(Novagen) 
(Shin & Noireaux, 2010; 2012; 
Sun et al., 2014) 
JS006 MG1655 araC- lacI- (Niederholtmeyer et al., 2015; 
Stricker et al., 2008) 
K12-A19 rna- gdhA2 relA1 spoT metB1 (Gesteland, 1966; D.-M. Kim et 
al., 1996)  
KC1 A19 speA- tnaA- tonA- endA- sdaA- sdaB- met+ (Michel-Reydellet et al., 2004) 
KC6 KC1 gshA- (Calhoun & Swartz, 2005a) 
KG6-der. KC6 rnb- ackA+ ef-tu+ hchA+ ibpA+ ibpB+ if-1+ if-2+ 
if-3+ 
US20130316397 
KGK10 KC6 gorB- trxB-HA (Knapp et al., 2007; Knapp & 
Swartz, 2007; Yin et al., 2012; 
Zawada et al., 2011) 
NMR1 A19 endA- met+ (Michel-Reydellet et al., 2004) 
NMR2 A19 speA- tnaA- tonA- endA- met+ (Michel-Reydellet et al., 2004) 
NMR4 A19 recD- endA- met+ (Michel-Reydellet et al., 2005) 
NMR5 A19 lambda-phage<>recBCD met+ (Michel-Reydellet et al., 2005) 
S30BL/Dna BL21(DE3) dnaK/J+ grpE+ (Kang et al., 2005) 
S30BL/DsbC BL21(DE3) dsbC+ (Kang et al., 2005) 
S30BL/GroE BL21(DE3) groEL/ES+ (Kang et al., 2005) 
S30OB F- omp ThsdSB(rB- mB-) gal dcm lacY1 
ahpC (DE3) gor522:: Tn10 trxB (Novagen) 
(Kang et al., 2005) 
S30OB/Dna S30OB dnaK/J+ grpE+ (Kang et al., 2005) 
S30OB/DsbC S30OB dsbC+ (Kang et al., 2005) 
S30OB/GroE S30OB groEL/ES+ (Kang et al., 2005) 
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Growth conditions 
Growth volume 
Historically, fermenters have been used to produce cell biomass. The original 
protocols utilized fermenters of up to 10 L in size to grow cells (Zubay, 1973). Building 
off of this, Swartz et al. demonstrated a 10 L scale (20 g/L wet pellet cell mass), which 
produced similar cell-free protein yield as shake-flask growth (Zawada & Swartz, 2005), 
but with the advantage of denser OD collection. The same protocol is cited by Sutro 
Biopharma in (Zawada et al., 2011), but utilizing a 200 L bioreactor also custom-
retrofitted with baffles. In both cases, feed rates of glucose are controlled to prevent 
acetate accumulation. Fermenters can be used to scale up biomass production, but 
suffer from increased labor and monitoring needed to collect data. 
In lieu, growth can be conducted on a shake-flask scale (1 L of cell culture in a 
2.8 L – 4 L Erlenmeyer flask), which yields about 1-2 mL of crude extract per L (Sun et 
al., 2013). Shake-flasks allow for quick production of biomass without fermenter 
maintenance. Protocols are focused on maintaining fast growth and aeration before 
capture at culture mid-log phase, and thus typically use baffled flasks. Examples of 
protocols using shake-flasks can be found at (Kigawa, Yabuki, Matsuda, Matsuda, 
Nakajima, Tanaka, & Yokoyama, 2004b; Sun et al., 2013; W. C. Yang, Patel, Wong, & 
Swartz, 2012). 
 For smaller volumes, a recent protocol by Kwon and Jewett demonstrates the 
first rapid production of cell-free at the 10 mL culture tube, allowing for the rapid 
exploration of ~100 strains per day using basic, readily available equipment (sonicator, 
small shaker, tabletop centrifuge) (Kwon & Jewett, 2015). Expression levels from the 10 
mL scale produce comparable protein to the 10 L scale. By allowing for small-scale but 
high throughput production, Kwon and Jewett’s protocol scales cell-free expression for 
exploring multiple rapidly-engineered strains or conditions. 
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Growth media 
While older protocols utilized 28°C growth (Zubay, 1973), the current standard 
protocol utilizes 37°C growth to encourage rapid protein production. This is driven by 
the knowledge that ribosome concentration correlates directly with growth rate 
(Bosdriesz, Molenaar, Teusink, & Bruggeman, 2015). There is evidence that 
temperature, effecting growth rate, has a direct correlation with extract productivity. In 
particular, Kigawa and colleagues have found that extracts have a linear productivity 
from 20°C to 37°C of growth, where CAT production yield at 20°C is 66% that of 37°C 
(Seki, Matsuda, Yokoyama, & Kigawa, 2008). Similarly, Nakano’s lab identified amino-
acid supplemented growth conditions that enabled cell-free growth of A19 at 42°C, 
yielding 40% more CAT production yield compared to 37°C growth (Yamane, Ikeda, 
Nagasaka, & Nakano, 2005). However, to date we are not aware of other protocols 
utilizing 42°C growth.  
 Growth medias vary from extract to extract perpetration, although in general 
medias used are complex, non-defined mixtures such as LB, 2xYT, etc. (Spirin & 
Swartz, 2008). Medias can be supplemented for limiting reagents; for example, 
asparagine, glutamine, and tryptophan (Yamane et al., 2005) is added to a complex 
media to encourage faster growth. For specific applications such as fermenter growth, 
glucose and amino acid concentration can be selectively monitored and fed to prevent 
acetate accumulation (Zawada & Swartz, 2005). In addition, in 2000 Kim and Choi 
identified the addition of phosphate and glucose to a 2xYT media (named 2xYT-PG) to 
be suppressive of phosphatase activity in the resulting extracts (R. G. Kim & Choi, 
2000). Phosphatase activity was found to consume energy sources PEP and amino 
acid cysteine. The group’s working hypothesis was supplementation of phosphate and 
glucose would prevent the cell from making its own phosphatases to produce inorganic 
phosphate. This media forms the basis for most modern cell-free preparations. It is 
noted that cell-free formulations for prototyping to-date have removed glucose from the 
media (Caschera & Noireaux, 2015; Shin & Noireaux, 2010; Sun et al., 2013) for 
unknown reasons. 
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Lysis methods 
Following culture, a number of options exist for lysing the cells and harvesting. 
Considerations of note when selecting a lysis method are lysis efficiency, scaling 
potential, ease of use, and preservation of native cell components. Different lysis 
techniques have different pros and cons and consequently, different protocols have cell 
disruption methods tailored to their applications. There has been relatively little 
innovation in this area; reviews addressing general cell lysis, such as one from 1986, 
provide good overviews of the different methods (Chisti & Moo-Young, 1986). We divide 
our discussion of lysis methods into five categories: mechanical (non-pressure), 
mechanical (pressure), acoustic, temperature, and chemical. 
 
Mechanical (non-pressure-based) lysis 
Mechanical methods utilize a grinding mechanism of action. These techniques 
involve the agitation of a suspension of cells in the presence of ceramic/glass beads, 
the motion of which results in crushing and grinding forces that break apart the cells and 
efficiently shears DNA (Miller, Bryant, Madsen, & Ghiorse, 1999). Industrial scale bead-
mills have been deployed for cellular lysis (Chisti & Moo-Young, 1986), although the use 
of “Bead-beater” type desktop devices have been preferred (Thompson & Chassy, 
1981) and adopted in cell-free protocols (Kigawa, Yabuki, Matsuda, Matsuda, Nakajima, 
Tanaka, & Yokoyama, 2004b; Shrestha, Holland, & Bundy, 2012; Sun et al., 2013). 
Beads are easily separated from the lysate by centrifugation/filtering and no expensive 
equipment is required, greatly reducing the financial barrier of entry into cell-free 
biology. The protocol also has utility in lysing non-E. coli such as cyanobacteria (Mehta, 
Evitt, & Swartz, 2015) and environmental samples from soil (Yeates, Gillings, Davison, 
Altavilla, & Veal, 1998). To maintain high protein concentrations necessary for cell-free 
expression, beads can also be filtered out of solutions post-processing (Sun et al., 
2013). As is the case with all mechanical lysis methods, localized sample heating that 
may denature native proteins is a concern in bead beating methods (Shrestha et al., 
2012). This problem is circumvented by limiting lysis to short bursts and by incubating 
the samples on ice between bursts (Sun et al., 2013). Perhaps the largest drawback to 
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this method of lysis is difficulty of scaling up to larger volumes as this method is typically 
conducted in 1-2 mL tubes. Bead mills present one avenue for scale-up but requires 
manual loading of extract. The ability to work in small volumes, however, is conducive to 
producing multiple distinct, small batches. Bead-beating is useful for studies requiring 
the production of multiple different extract batches, as is the case when conducting 
protocol modifications.  
 
Mechanical (pressure-based) lysis 
High pressure disruption mechanisms such as impinge homogenizers are among 
the earliest and most widely utilized methods for lysing cells for the purpose of 
preparing extracts (Chisti & Moo-Young, 1986). These work by forcing cell suspensions 
through a narrow aperture under high pressure. The high-velocity flow of cells either 
impinges on an opposite high-pressure stream of cells or a rigid valve/nozzle surface. 
The resulting shear rates and rapid decompression are thought to be critically important 
in the formation of inverted membrane vesicles in the resultant extracts (Jewett, 
Calhoun, Voloshin, Wuu, & Swartz, 2008). Because the enzymes essential to the 
oxidative phosphorylation pathway must be membrane-associated to function, the 
possibility of their presence is worth considering when selecting a lysis method. Access 
to the oxidative phosphorylation pathway potentially increases the metabolic efficiency 
of extracts, enabling more economical and productive strategies for powering the 
transcription-translation machinery.  
For E. coli extracts, different types of impinge homogenizers are currently in use, 
ranging from French Press-style homogenization (Caschera & Noireaux, 2014; D. M. 
Kim & Choi, 1996; T. W. Kim et al., 2006)  to Avestin™-type homogenization (Jewett et 
al., 2008; Liu, Zawada, & Swartz, 2005; Sitaraman et al., 2004; W. C. Yang et al., 
2012). Both types of homogenizers allow for scaling of batches; French-press 
homogenizers scale up to the size of the press (typically 30 mL), while Avestin©-type 
homogenizers allow for feeding of cell biomass. 
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Acoustic lysis 
Sonication, or acoustic lysis, relies on ultrasound energy (15-20kHz) to disrupt 
cells in solution. The mechanism of lysis is thought to be related to cavitation, a 
phenomena where microbubbles form at nucleation sites, absorb energy and burst, 
releasing mechanical shock waves that disrupts the cell wall and can shear DNA (Chisti 
& Moo-Young, 1986). There are relatively few examples of sonication being used as a 
lysis method for E. coli cell-free protein synthesis, with an early example failing due to 
“sample heating and difficulty of management” (Kigawa, Yabuki, Matsuda, Matsuda, 
Nakajima, Tanaka, & Yokoyama, 2004b). In 2012, Bundy and colleagues re-attempted 
sonication as a lysis technique, and were able to successfully demonstrate protein 
yields comparable to that of high-pressure homogenization, albeit with significant 
optimization of the sonication burst times and cooling times (Shrestha et al., 2012). In 
this study, temperature was also not shown to be a damaging factor. This was followed 
by a study from Kwon and Jewett optimizing energy input to cell-strain and processing 
volume, which found a surprising strain-dependence (Kwon & Jewett, 2015). It is 
anticipated that sonication will be studied further for E. coli cell-free systems. Like bead-
beating, benefits of sonication include low startup costs and the ability to work with very 
small volumes. 
 
Temperature based-lysis 
Temperature-based lysis relies on freeze-thaw cycles to disrupt cellular 
membranes, and is one of the easiest methods of cellular disruption for producing 
purified proteins (Johnson & Hecht, 1994; Ron, Kohler, & Davis, 1966). This lysis can 
take place with or without enzymatic or chemical assistance such as lysosome. If 
successful, the method does not require advanced materials (other than liquid nitrogen 
or -80 C storage). However, freeze-thaw has not been demonstrated successfully for E. 
coli cell-free systems, with no appreciable expression detected despite a 99.6%-99.9% 
lysis efficiency (Shrestha et al., 2012). This is relatively surprising, as freeze-thaw in 
20% glycerol has been demonstrated for Trichoplusia ni (insect) cell-lines (Ezure et al., 
2006). 
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Chemical lysis 
Chemical lysis relies on the use of enzymes or detergents to remove cell walls, 
typically used in the context of protein purification. Enzymes such as lysozyme 
(peptidoglycan layer in E. coli) or benzonase (nuclease to remove DNA and RNA) are 
commonly utilized in tandem with defined detergents such as Tween-20, Triton-X, or 
RIPA buffer or commercial mixtures such as BugBuster (Novagen) or CellLytic X 
(Sigma). To our knowledge, there is no successful production of a coupled cell-free 
system using chemical lysis, although attempts using lysozyme with freeze-thaw have 
been unsuccessful (Shrestha et al., 2012). While chemical lysis has been used for 
anaerobic cell-free activity assays (Kuchenreuther, Shiigi, & Swartz, 2014), no coupled 
transcription-translation has been demonstrated. 
 
Clarification 
 
Following lysis, the resultant solution is typically extremely viscous and difficult to 
manipulate. For this reason, the lysis step is always followed by a clarification step in 
which the lysate is spun down in a centrifuge to separate cellular debris from the soluble 
substrates (active enzymes, small molecules, and co-factors, necessary to drive 
coupled transcription-translation). Although crude extract can be used with no 
clarification step, aside from issues arising from viscosity, background expression is 
increased relative to clarified extracts (T. W. Kim et al., 2006). Traditionally, clarification 
has consisted of (2x 30 min) 30,000 x g spins, a process that comprises a large portion 
of the processing time (resulting in term S30 extract) (Nirenberg & Matthaei, 1961). Two 
washes were later found to be unnecessary, with 1 wash sufficient to obtain equivalent 
signal (Liu et al., 2005). 
In 2006 Kim (DM) and colleagues demonstrated a radical shift in clarification 
protocols by showing that one 12,000 x g spin for 10 minutes was successful in 
maintaining expression (T. W. Kim et al., 2006). Interestingly, cell-free expression from 
a 12,000 x g spin followed by no-dialysis was similar to that of the traditional 2 x 30,000 
x g spins, and crude lysate with no processing showed only marginally less (20%) 
expression. This finding was reproduced independently, demonstrating a 30% 
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increased yield using S12 over S30 (Pedersen, Hellberg, Enberg, & Karlsson, 2011). 
S12 preparations also demonstrated increased co-factors relative to S30 preparations 
(T.-W. Kim, Keum, et al., 2007a). S12 extract demonstrated workable viscosity and 
decreased background expression, but was strain specific to the Rosetta, BL21, and 
BL21-Star lines. Subsequently, 12,000 x g spins have become widely adopted for 
preparing cell-free systems from compatible strains (Kwon & Jewett, 2015; Shrestha et 
al., 2012; Sun et al., 2013).  
 
Runoff  
A runoff reaction is typically conducted after clarification of the lysate, 
presumably to release ribosomes from bound mRNA and degrade leftover, sheared 
mRNA and DNA from the host strain (Jermutus, Ryabova, & Plückthun, 1998; 
Nirenberg, 1963). Before the runoff reaction, solutions are typically clear; afterwards, 
however, the solutions become cloudy, indicating degradation or modification (Sun et 
al., 2013). However, there has been little experimental evidence of this hypothesis, and 
it is a rich area of potential further exploration. Traditionally, the runoff reaction occurs at 
37°C for 80 minutes, and mixes clarified lysate with a pre-incubation mix of Tris, Mg, 
ATP, DTT, amino acids, PEP, and pyruvate kinase. However, Swartz and colleagues 
first reported that the pre-incubation mix was unnecessary to obtain signal (Liu et al., 
2005), and that a 37°C, 80-minute incubation of the post-clarified lysate was sufficient. 
In addition, ribosome release as the reason for the runoff is called into question, with a 
new hypothesis that the runoff activated activators or degraded inhibitors. Adding to the 
confusion, in 2015 Kwon and Jewett identified a strain-specific runoff property, with 
BL21-Star (DE3) strains not requiring runoff to activate protein production and other 
strains requiring different experimentally-optimized runoff steps (Kwon & Jewett, 2015). 
While current protocols for prototyping use a set 80-minute runoff without pre-incubation 
(Sun et al., 2013), this area is ripe for future research. 
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Dialysis 
After the runoff reaction, lysates are typically re-clarified by centrifugation to 
remove substrates accumulated during the reaction and dialyzed against a final S30 run 
buffer at 4 C (Sun et al., 2013). Traditionally, the dialysis step varies in length of time 
from one cycle of 3 hours (Sun et al., 2013) or 18 hours (Zubay, 1973) to 45 minutes x 4 
cycles (Kigawa, Yabuki, Matsuda, Matsuda, Nakajima, Tanaka, & Yokoyama, 2004b). 
However, when explored with the runoff Swartz and colleagues found the dialysis step 
to be unnecessary, with no statistical difference between 0 – 4 dialysis cycles (Liu et al., 
2005). This was confirmed by Kim (DM) and colleagues, who found dialysis un-
necessary in the standard protocol, except when used after a 80 minute runoff step, 
presumably to remove by-products from the runoff (T. W. Kim et al., 2006). A potential 
added benefit of removing the dialysis step is the retention of cofactors that would 
otherwise pass through the 10kDa membrane used. There currently is a mix of 
protocols used, with some protocols utilizing dialysis (Garamella, Marshall, Rustad, & 
Noireaux, 2016; Sun et al., 2013; W. C. Yang et al., 2012) and others omitting dialysis 
(Kwon & Jewett, 2015; Shrestha et al., 2012). The effect of dialysis on extract 
composition and on prototyping ability is another area ripe for future research. 
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E. coli ENERGY REGENERATION 
The development of more efficient methods for energizing cell-free protein 
synthesis mirrors the maturation of cell-free extracts as a platform for synthetic biology 
(Figure 3). For decades, the ability to leverage the advantages of cell-free systems in 
industrial applications was limited by inefficient methods for regenerating ATP 
necessary for protein synthesis. In addition to being unable to sustain protein synthesis 
beyond an hour as a result of substrate instability (D. M. Kim & Choi, 1996; D.-M. Kim & 
Swartz, 2000b; R. G. Kim & Choi, 2000), early energy regeneration systems relied on 
prohibitively expensive substrates. These issues were gradually addressed by enabling 
and utilizing increasingly extended pieces of native cell metabolism to more efficiently 
drive protein synthesis. Much of the exploration in this area was not through building 
synthetic pathways, but rather through the observation that cell-free lysates innately 
conserve complex central metabolism, such as pathways for glycolysis and oxidative 
phosphorylation (Figure 4). For example, for oxidative phosphorylation to work, all 
enzymes in the TCA cycle and in the electron transport chain must be present and 
functional (Jewett et al., 2008; Jewett & Swartz, 2004a).  
  As a result, the latest cell-free systems feature a thousand-fold improvement in 
the relative cost of energy substrate demonstrated (Caschera & Noireaux, 2015) and 
protein synthesis can be extended to ten hours in simple batch mode (Caschera & 
Noireaux, 2014). This is a direct result of being able to exploit E. coli sugar metabolism 
in its entirety. The demonstration of such extensive, intact native machinery and the 
ability to manipulate its utility signals an important paradigm shift in cell-free systems. 
Rather than a black-box system used for simple protein production, cell-free extracts 
have evolved into a complex and valuable prototyping environment.  
 
General requirements 
Although not constrained by energy costs associated with growth and 
maintenance in whole cells, cell-free extracts are still subject to stringent energy 
requirements posed by high-volume protein expression. Two molecules of ATP and two 
GTP are consumed in the formation of each peptide bond. Resource limitation is an 
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important consideration in maximizing yields in protein production applications of cell-
free reactions but is equally important in successfully implementing multi-step pathways 
and ensuring fidelity in rapid prototyping functions. Accordingly, a robust energy 
regeneration system is essential to maximizing extract performance across the board 
for all cell-free protein synthesis applications. This energy regeneration system must 
also be capable of avoiding inorganic phosphate accumulation (Spirin & Swartz, 2008) 
while maintaining pH within physiological range. We divide our discussion of energy 
regeneration in rough chronological order of development: single-step (substrate level) 
phosphorylation, multi-step pathway phosphorylation and oxidative phosphorylation.   
 
 
Figure 3. Energy sources to feed cell-free metabolism, arranged by year. Top of 
figure shows “major” breakthroughs in energy metabolism, while bottom of figure shows 
other breakthroughs. 
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Figure 4. Simplified map of E. coli cell-free metabolism.  Map is divided into 
Glycolysis, TCA  Cycle, and Fermentation; areas in green are energy sources that have 
been explored for cell-free metabolism.  
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Single-step (substrate level) phosphorylation 
The earliest iterations of cell-free extracts utilized molecules containing high-
energy phosphate bonds as their source of energy (Figure 5). This paradigm remained 
relatively unchanged for many years. The most popular has been phosphoenolpyruvate 
(PEP) (Zubay, 1973). While PEP and pyruvate kinase (PK) together produced ATP, 
Spirin and colleagues hypothesized that acetyl phosphate could provide a cheaper 
alternative, and demonstrated equivalent signal with acetyl phosphate alone (Ryabova 
et al., 1995). This was the first evidence substrate-level phosphorylation was relatively 
independent of high-energy molecule chosen, and endogenous enzymes could be 
utilized.1 Four years later, Yokoyama and colleagues showed a completely exogenous 
system, creatine phosphate (CP), could also be used in conjunction with enzyme 
creatine kinase (CK) (Kigawa et al., 1999). CP/CK was tested after finding that PEP had 
inhibitory effects on cell-free reactions, which would later be attributed to inorganic 
phosphate accumulation from non-specific phosphatase degradation (D.-M. Kim & 
Swartz, 1999). Pyruvate kinase, creatine kinase, and acetate kinase each transfer their 
high-energy phosphate bonds to ADP to form ATP via substrate-level phosphorylation.  
 
                                                
1 It is likely that if PEP was supplied alone, the system would still produce ATP from the 
endogenous pyruvate kinase present in the extracts. 
 
Figure 5. Substrate-level 
phosphorylation. Shown are 
three substrate-level 
phosphorylation modes 
utilized for cell-free systems: 
phosphoenolpyruvate/pyruvate 
kinase, acetyl 
phosphate/acetate kinase, and 
creatine phosphate/creatine 
kinase. 
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Although single-step phosphorylation of ATP is simple and effective in energizing 
cell-free protein synthesis, the use of PEP, CP, and AP has a number of drawbacks. 
The utility of high-energy phosphate molecules as energy donors is limited by their 
susceptibility to nonspecific attack by endogenous phosphatases (D.-M. Kim & Swartz, 
1999; 2000b). The result is very transient expression as the energy molecules are 
quickly degraded. 70% of PEP was degraded into pyruvate and inorganic phosphate 
after a 30-minute incubation in S30 extract in the absence of DNA, indicating the 
presence of an unproductive sink for the supplied energy source (D.-M. Kim & Swartz, 
1999). Protein yield is further limited by the accumulation of high concentrations of 
inorganic phosphate in solution resulting from the unproductive cleavage of the high-
energy phosphate bonds. Reactions quickly terminate when phosphate concentrations 
reach 40-50 mM as a result of chelation of magnesium (T.-W. Kim, Oh, et al., 2007b), 
which is essential to biologically activating ATP and the function of essential enzymes 
(D.-M. Kim & Swartz, 1999). Altogether, this results in reactions not exceeding 1-2 
hours in duration. To some extent, replenishing magnesium and the energy source in 
the reaction has been demonstrated to extend the duration of protein synthesis but such 
an approach rules out simple batch-mode reactions (D.-M. Kim & Swartz, 2000b). 
Another solution explored addition of inorganic phosphate and glucose to the growth 
medium in which the cells are grown, which limited phosphatase activity in extracts by 
suppressing expression of phosphatases during growth (R. G. Kim & Choi, 2000).  
 
Multi-step pathway phosphorylation  
A number of different systems from 1999 onwards were developed to address 
the weaknesses inherent in systems dependent on high-energy phosphate-bonded 
compounds.  These strategies relied on utilizing multi-step enzymatic pathways in order 
to more efficiently harness the energy of the high-energy phosphate compounds. By 
utilizing multi-step pathways, substrates would be less prone to phosphatase attack and 
a spike in inorganic phosphate concentrations. In addition, ATP generation could be 
extended over the course of the reaction. The first multi-step system generated acetyl 
phosphate through the addition of pyruvate and pyruvate oxidase in the presence of 
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thiamine pyrophosphate (TPP) and flavin adenine dinucleotide (FAD) (D.-M. Kim & 
Swartz, 1999). Substrate-level phosphorylation of acetyl phosphate produces ATP by 
endogenous acetate kinase. This method is more resistant to phosphatase activity as a 
lower, sustained concentration of acetyl phosphate is lower relative to the Km of the 
phosphatases. Importantly, the use of an un-phosphorylated substrate serves as an 
inorganic phosphate sink, thereby preventing phosphate buildup by coupling the activity 
of pyruvate oxidase to the inorganic phosphate produced by acetyl kinase.  
 In 2001, the PANOx system (PEP, amino acids, NAD+, oxalic acid) debuted as a 
highly rationally-engineered multi-step pathway phosphorylation system (D.-M. Kim & 
Swartz, 2001) (Figure 6). PANOx employs multiple enzymatic steps to more efficiently 
harness the energy of high-energy phosphorylated molecules. This system utilizes PEP 
as the main source of energy but benefits from substrate-level phosphorylation at two 
points: the conversation of PEP to pyruvate, and the conversion of acetyl phosphate to 
acetate. The latter conversion is enabled by the addition of NAD+ and CoA, which drive 
the conversation of pyruvate to acetate. Addition of oxalic acid prevents the 
nonproductive reverse reaction of pyruvate to PEP by inhibiting the activity of PEP 
synthase (D.-M. Kim & Swartz, 2000a), thereby driving flux forward. Finally, amino acids 
were supplemented to replace degradation of arginine, serine, tryptophan, and cysteine 
(Michel-Reydellet et al., 2004). The second generation of this system, PANOx-SP 
adapted the PANOx environment to look more like the cell by replacing polyethylene 
glycol with spermidine and putracine (the SP of PANOx-SP), and removing HEPES 
buffer (Jewett & Swartz, 2004a). These changes were made to encourage metabolism 
of pyruvate, as pyruvate alone provided only 20% of the signal of PEP. The PANOx, 
PANOx-SP, and variants thereof are still widely in use as energy regeneration methods, 
both in academic settings (T Michaele Holland & Bundy, 2012; Hong et al., 2014; Kwon 
& Jewett, 2015) and in commercial settings (Roche, now Biotechrabbit RTS-100). 
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Figure 6. PANOx energy regeneration system. Underlined are PANOx additives 
(amino acids not shown). In grey are non-productive pathways. In italics are enzymes. 
ATP is generated from conversion of PEP to pyruvate via pyruvate kinase, and 
converstion of acetyl phosphate to acetate via acetate kinase. Figure adapted from (Jim 
Swartz, 2006) 
 
 Also in 2001, glucose-6-phosphate (G6P) was found as sufficient to energize 
cell-free reactions (D.-M. Kim & Swartz, 2001). This finding was particularly notable, as 
G6P is 9 steps removed from pyruvate in the glycolytic pathway. At worst case, G6P 
required conversion to fructose-1,6-biphosphate (F1,6-BP) before substrate-level 
phosphorylation; at best case, the catabolic machinery for glycolysis remained intact in 
cell-free extracts. Logically, it follows that any of the intermediates in the glycolytic 
pathway can be utilized as the starting substrate for ATP regeneration. Following this 
line of reasoning, 3-phosphoglycerate (3-PGA), a glycolytic intermediate two steps 
upstream of PEP, was employed as a primary energy source to offer further 
improvement on the existing ATP regeneration paradigm. By co-opting endogenous 
enzymes to generate PEP in situ from 3-PGA, Chatterjee and colleagues were able to 
extend the duration of protein synthesis well beyond the limit of an analogous system 
utilizing PEP (Sitaraman et al., 2004). The continuous synthesis of PEP allowed the 
system to evade the phosphatase activity that hampered ATP regeneration by 
maintaining PEP at low enough concentrations to avoid premature degradation. The 3-
PGA system would form the basis of prototyping extracts from Noireaux, Murray, and 
colleagues (Shin & Noireaux, 2010; Sun et al., 2013). Similarly, F1,6-BP, which is 
further upstream than 3-PGA, was demonstrated to outstrip 3-PGA as an energy donor 
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as theoretically one molecule of FBP would yield more ATP than intermediates 
downstream (T.-W. Kim, Keum, et al., 2007a).  
The glycolytic pathway, in its entirety, has also been leveraged for the cheap and 
efficient replenishment of ATP. In such a situation, glucose, the cost of which is 
negligible relative to most other energy sources, can serve as an economical and 
efficient substrate for energizing protein expression. In contrast to traditional substrate-
level phosphorylation reactions that yield only one mole of ATP per mole of costly 
energy molecule, one mole of glucose can yield 2 or 3 moles of ATP, respectively. A 
landmark moment was the usage of glucose, notable as a cheap substrate, for 
energizing cell-free systems in parallel with NMPs (vs. NTPs) (Calhoun & Swartz, 
2005c). While effective, glucose metabolism was found to decrease the pH of the 
reaction below the physiological range as a result of organic acid production (Calhoun & 
Swartz, 2005b), thereby requiring extensive buffering. Reactions utilizing glucose 
required the addition of inorganic phosphate in addition to pH buffering to express on 
par with G6P. One approach coupled glucose metabolism with creatine phosphate and 
creatine kinase in a complementary energy regeneration system (T.-W. Kim, Oh, et al., 
2007b). The normally inhibitory inorganic phosphate from creatine phosphate 
metabolism served as the phosphate source necessary to activate glucose metabolism. 
Although the amount of protein yielded by this combination of resources was high, the 
return to creatine phosphate offset this advantage with a much higher cost to yield ratio. 
Another iteration refined the parameters for glucose utilization and dramatically 
extended reaction duration and productivity, resulting in a six-hour reaction yielding 1.8 
mg/mL of protein (T.-W. Kim, Kim, Oh, & Kim, 2008). This was accomplished by 
growing the cells in the presence of glucose and phosphate, further fortifying the pH 
buffering capacity, and utilizing the S12 extract preparation method to preserve 
cofactors. 
Recently, cell-free systems have been engineered to use complex sugars in 
order to prevent pH issues, maintain cost advantage, and allow for long-lasting energy 
release. Wang and Zhang (YHP) in 2009 demonstrated that maltodextrin, in 
combination with supplemental maltodextrin phosphorylase and phosphoglucomutase, 
could effectively energize cell-free reactions at very low cost (Y. Wang & Zhang, 2009). 
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This strategy integrates phosphorolysis to serve as an inorganic phosphate sink and 
glycolysis in addition to the PANOx pathway to generate ATP. Each glucose equivalent 
in maltodextrin can produce one more net ATP relative to glucose by consuming 
inorganic phosphate rather than ATP in the formation of G6P. Maltodextrin resulted in 
less pH perturbations (relative to glucose, PEP, and G6P in analogous systems), and in 
more homeostatic and stable reaction conditions. Further refinement of the 
polysaccharide approach utilizing starch and glycogen demonstrated that protein 
synthesis could continue for 12 hours in a simple batch mode, yielding 1.7 mg/mL of 
protein without addition of exogenous enzymes (H.-C. Kim, Kim, & Kim, 2011). Kim et 
al. also demonstrated the maintenance of a steady supply of ATP without drastic 
alteration of pH which they postulated might explain the improved solubility of 
synthesized protein. Quantification of the ATP and starch levels after cessation of 
transcription at 12 hours showed that only 20% of the starch had been consumed and 
ATP concentrations were still constant, implying that ATP supply was not the limiting 
factor. In an effort to improve upon the system by introducing a gradually released 
phosphate reservoir, bypassing the presence of potentially inhibitory amounts of 
inorganic phosphate, hexametaphosphate was recently utilized in place of potassium 
phosphate (Caschera & Noireaux, 2015). An approach combining the strengths of the 3-
PGA system with maltose, a disaccharide acting as an inorganic phosphate sink and 
secondary energy source was also pursued (Caschera & Noireaux, 2013).  
 
Oxidative Phosphorylation 
The Cytomim system was originally produced to metabolize (cheaper) pyruvate 
in lieu of (more expensive) PEP, with the working hypothesis that conditions more 
representative of the cytoplasm would be necessary for pyruvate utilization (Jewett & 
Swartz, 2004b; 2004a). Interestingly, however, Jewett and Swartz discovered that ATP 
generation and protein synthesis continued beyond the depletion of pyruvate, the 
presumed energy substrate. On follow-up, the depletion of glutamate and formation of 
TCA cycle intermediates was observed, demonstrating that glutamate alone could serve 
as a stand-alone energy substrate (Jewett et al., 2008). This process was found to be 
heavily oxygen-dependent, thereby confirming that oxidative phosphorylation could be 
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activated in cell-free extracts. Biochemical inhibitors of the electron transport chain also 
significantly reduced the protein yielded by the cell-free system. This represents a 
substantial shift in thinking, as the TCA cycle as well as the electron transport chain are 
necessary. It was theorized that lysis methods causing high shear rates (eg. high-
pressure homogenization) allows inverted membrane vesicles (IMVs) upon which 
oxidative phosphorylation can occur. 
 
Energy Regeneration in the context of Synthetic Biology 
 While there has been extensive innovation in energy regeneration in cell-free 
systems, less clear are the conditions that are necessary to enable synthetic biology 
applications to function, such as the rapid prototyping of circuits (Garamella et al., 2016; 
Sun et al., 2014; Takahashi et al., 2015) and of pathways (Karim & Jewett, 2016; Wu, 
Culler, Khandurina, Van Dien, & Murray, 2015). For circuit prototyping specifically, one 
can assume that interactions such as protein-binding strength to operators, or weak Km 
binding events, are more critical than pure protein expression. In addition, native 
polymerases are favored over T7 polymerase to better emulate cellular conditions (Shin 
& Noireaux, 2010). With a goal of prototyping to match cellular function and implement 
complexity (versus pure protein production), it is likely that re-evaluation of existing 
approaches will be necessary to support this new application. To date, two protocols 
have been used for circuit prototyping: (1) a protocol utilizing bead-beating and 3-PGA 
energy regeneration (Sun et al., 2013), and (2) a protocol mixing bead-beating or 
French-press preparation and 3-PGA with maltodexrin and/or maltose (Garamella et al., 
2016). In addition, the protocol of (Sun et al., 2013) has been used for prototyping 
pathways for 1,4-BDO (Wu et al., 2015) and violacein (Nguyen, Wu, Guo, & Murray, 
2015), as well as a modified PANOx-SP run off of T7 RNA polymerase for n-butanol 
(Karim & Jewett, 2016). However, there has been no published work on engineering of 
the cell-free protocol to specifically support circuit prototyping. 
While we now know that cell-free systems contain large amounts of intact 
metabolism, there is also a need to apply –omics technologies (genomics, proteomics, 
metabolomics, transcriptomics, glycomics) to better understand the cell-free “black-box.” 
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Since the dense period of discovery from 1999 – 2011, there has been a lack of 
published work seeking to understand the extent to which central metabolism can be 
activated and manipulated. This is particularly compelling with the new tools available 
since the bulk of discovery was conducted, including RNAseq (Mortazavi, Williams, 
McCue, Schaeffer, & Wold, 2008), high-throughput gene synthesis and assembly 
(Kosuri et al., 2010), and high-throughput gene sequencing (Shendure, Mitra, Varma, & 
Church, 2004). It is also increasingly evident that cell-free systems are not uniform, 
standard “collections” of lysates, but rather complex compositions that are affected by 
the multiple variables of preparation and energizing. These complex compositions may 
require standardization of preparation, or individual analysis per batch to understand 
variability that result extract-to-extract (Takahashi et al., 2014; 2015). Attempts by 
Panke and colleagues to conduct real-time analysis on lysates is a start at 
understanding this complexity (Bujara, Schümperli, Pellaux, Heinemann, & Panke, 
2011).  
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